James Yang Liu's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 6,289 Common Stock done . Disclosure was reported to the exchange on March 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 6,289 | 6,289 (0%) | 0% | - | Common Stock | |
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 6,289 | 12,578 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.11 per share. | 26 Mar 2026 | 2,578 | 3,711 (0%) | 0% | 4.1 | 10,596 | Common Stock |
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2025 | 18,000 | 18,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 18,867 | 18,867 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnostics Inc | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnostics Inc | James Yang Liu | Sr Dir., Cntlr, PAO, Int PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnostics Inc | James Yang Liu | Controller, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 57,065 | 57,065 | - | - | Option to Purchase Common Stock |